fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CHMP positive opinion for Omicron KP.2-adapted COVID-19 vaccine in the EU – Pfizer + BioNTech

Written by | 7 Oct 2024

Pfizer  and BioNTech SE announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has recommended marketing authorization for the companies’… read more.

Most pregnant people got vaccinated for COVID-19 in 2022

Written by | 5 Oct 2024

A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release. The study, co-led… read more.

Pain identified as dominant symptom in long Covid

Written by | 31 Aug 2024

Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL (University College London) researchers. The study,… read more.

FDA approval & authorization for Omicron KP.2-adapted COVID-19 Vaccine – BioNTech SE + Pfizer

Written by | 30 Aug 2024

Pfizer Inc. and BioNTech SE announced that the FDA has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (COVID-19 Vaccine, mRNA),… read more.

MS not associated with COVID-19 relapse after vaccination

Written by | 15 Aug 2024

People with multiple sclerosis (MS) do not appear to be at an increased risk of relapse after COVID-19 vaccination, researchers reported on August 14, 2024 in Neurology. “People… read more.

Pandemic’s impact on primary care: Significant drop in visits and uneven telehealth use across patient groups

Written by | 13 Aug 2024

The COVID-19 pandemic likely worsened disparities in access to primary care. The goal of this study was to quantify the nationwide decline in primary care visits and the… read more.

Around 160,000 joint replacement surgeries lost by COVID-19 pandemic, study finds

Written by | 4 Aug 2024

Nearly nine months of joint replacement surgery has been lost – around 160,000 fewer operations –  since the start of the COVID-19 pandemic, a new study led by… read more.

Common respiratory infections may have protected children from COVID-19, study suggests

Written by | 22 Jun 2024

Analyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect… read more.

Moderna files FDA application for the JN.1 targeting COVID-19 vaccine

Written by | 11 Jun 2024

Moderna, Inc. announced that it has submitted an application to the FDA for review of its Spikevax 2024-2025 formula, targeting the SARS-CoV-2 variant JN.1. “For four years, Moderna… read more.

Misleading COVID-19 headlines from mainstream sources did more harm on Facebook than fake news

Written by | 1 Jun 2024

Since the rollout of the COVID-19 vaccine in 2021, fake news on social media has been widely blamed for low vaccine uptake in the United States — but research by MIT… read more.

Young adults reduced drinking during and after pandemic

Written by | 7 May 2024

A new study examined the drinking levels and patterns of young adults before, during and after the pandemic. The researchers found alcohol use and alcohol-related problems substantially decreased… read more.

Older adults with diabetes experienced functional decline during the COVID-19 pandemic

Written by | 22 Apr 2024

Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during the COVID-19 pandemic…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.